Cargando…

PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis

Autophagy plays a critical role in the progression of nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). Protein tyrosine phosphatase receptor type O (PTPRO) was recently identified as a tumor suppressor, but little is known about its role in NASH. Here, we investigated the role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wenjie, Hou, Jiajie, Wang, Xiaochen, Jiang, Runqiu, Yin, Yin, Ji, Jie, Deng, Lei, Huang, Xingxu, Wang, Ke, Sun, Beicheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496227/ https://www.ncbi.nlm.nih.gov/pubmed/25826083

Ejemplares similares

Clinicopathological Features and Prognostic Factors of Young Patients With Surgically Treated Liver Cancer
por: Zhang, Wenjie, et al.
Publicado: (2015)

Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma
por: Tang, Junwei, et al.
Publicado: (2015)

PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism
por: Dai, Weixing, et al.
Publicado: (2022)

PTPRO is a therapeutic target and correlated with immune infiltrates in pancreatic cancer
por: Hou, Xuben, et al.
Publicado: (2021)

Age-related decline in hippocampal tyrosine phosphatase PTPRO is a mechanistic factor in chemotherapy-related cognitive impairment
por: Yao, Zhimeng, et al.
Publicado: (2023)

Depending on the stage of hepatosteatosis, p53 causes apoptosis primarily through either DRAM-induced autophagy or BAX
por: Liu, Kai, et al.
Publicado: (2013)

IL-22 is related to development of human colon cancer by activation of STAT3
por: Jiang, Runqiu, et al.
Publicado: (2013)

Comprehensively Analyze the Prognosis Significance and Immune Implication of PTPRO in Lung Adenocarcinoma
por: Lin, Zhimin, et al.
Publicado: (2023)

LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway
por: Ji, Jie, et al.
Publicado: (2015)

Basigin deficiency prevents anaplerosis and ameliorates insulin resistance and hepatosteatosis
por: Ryuge, Akihiro, et al.
Publicado: (2021)

PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2
por: Dong, H, et al.
Publicado: (2017)

The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion
por: Jiang, Runqiu, et al.
Publicado: (2017)

Adipocyte-derived Periostin mediates glucocorticoid-induced hepatosteatosis in mice
por: Wan, Jian, et al.
Publicado: (2019)

Inhibition of MTA1 by ERα contributes to protection hepatocellular carcinoma from tumor proliferation and metastasis
por: Deng, Lei, et al.
Publicado: (2015)

A medium-chain fatty acid analogue prevents hepatosteatosis and decreases inflammatory lipid metabolites in a murine model of parenteral nutrition-induced hepatosteatosis
por: Cho, Bennet S., et al.
Publicado: (2023)

Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients
por: Li, Shao-ying, et al.
Publicado: (2014)

CRYP-2/cPTPRO is a neurite inhibitory repulsive guidance cue for retinal neurons in vitro
por: Stepanek, Laurie, et al.
Publicado: (2001)

Ceramides: Nutrient Signals that Drive Hepatosteatosis
por: Summers, Scott A.
Publicado: (2020)

MiR-6869-5p Induces M2 Polarization by Regulating PTPRO in Gestational Diabetes Mellitus
por: Wang, Pingping, et al.
Publicado: (2021)

Bidirectional transcription of Linc00441 and RB1 via H3K27 modification-dependent way promotes hepatocellular carcinoma
por: Tang, Junwei, et al.
Publicado: (2017)

The Adenosine Monophosphate (AMP) Analog, 5-Aminoimidazole-4-Carboxamide Ribonucleotide (AICAR) Inhibits Hepatosteatosis and Liver Tumorigenesis in a High-Fat Diet Murine Model Treated with Diethylnitrosamine (DEN)
por: Gao, Jianlong, et al.
Publicado: (2018)

PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy
por: Huang, Yi-Teng, et al.
Publicado: (2013)

Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets
por: Zuo, Qianying, et al.
Publicado: (2021)

Hepatosteatosis from Lysosomal Acid Lipase Deficiency
por: Zandanell, Stephan, et al.
Publicado: (2018)

Role of hepatosteatosis in the prognosis of COVID 19 disease
por: Çoraplı, Mahmut, et al.
Publicado: (2021)

Evaluation of Epstein-Barr Virus Latent Membrane Protein 2 Specific T-Cell Receptors Driven by T-Cell Specific Promoters Using Lentiviral Vector
por: Yang, Dongchang, et al.
Publicado: (2011)

Detection of Impaired Cognitive Function in Rat with Hepatosteatosis Model and Improving Effect of GLP-1 Analogs (Exenatide) on Cognitive Function in Hepatosteatosis
por: Erbaş, Oytun, et al.
Publicado: (2014)

MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis
por: Wu, Heng, et al.
Publicado: (2016)

PTPRO predicts patient prognosis and correlates with immune infiltrates in human clear cell renal cell carcinoma
por: Gan, Jinfeng, et al.
Publicado: (2020)

PTPRO-related CD8(+) T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer
por: Dong, Hongmei, et al.
Publicado: (2022)

Study on the Relationship Between PTPRO Methylation in Plasma and Efficacy Neoadjuvant Chemotherapy in Patients with Early Breast Cancer
por: Liu, Xiang-Wei, et al.
Publicado: (2023)

Autophagy and Tumorigenesis
por: Roy, Srirupa, et al.
Publicado: (2010)

The emerging roles of circular RNA-mediated autophagy in tumorigenesis and cancer progression
por: Yuan, Yuan, et al.
Publicado: (2022)

The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling
por: Asbagh, Layka Abbasi, et al.
Publicado: (2014)

Nutrigenomics Therapy of Hepatisis C Virus Induced-hepatosteatosis
por: Liu, Qing, et al.
Publicado: (2010)

A FATal AP-1 dimer switch in hepatosteatosis
por: Bakiri, Latifa, et al.
Publicado: (2014)

NTCP deficiency in mice protects against obesity and hepatosteatosis
por: Donkers, Joanne M., et al.
Publicado: (2019)

Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome
por: Erman, Hande, et al.
Publicado: (2020)

Late-Onset Lipid Storage Myopathy with Fatal Hepatosteatosis
por: Yavuz, Arda, et al.
Publicado: (2020)

OR09-2 Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets
por: Zuo, Qianying, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3i475u0pmbi1gn938rkm2hs0u0